Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review

BMJ Open

Volumn 5, Issue 10, 2015, Pages

  Usher Smith, Juliet A ^a   Silarova, Barbora ^b   Schuit, Ewoud ^c,d   Moons, Karel G M ^c   Griffin, Simon J ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ANXIETY; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HEALTH CARE PERSONNEL; HUMAN; PATIENT; PHYSIOLOGY; PRIMARY PREVENTION; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT;

ANXIETY; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; HEALTH PERSONNEL; HUMANS; PATIENTS; PRIMARY PREVENTION; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 85016277018     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/BMJOPEN-2015-008717     Document Type: Review

References (49)

1. World Health Organisation. Global status report on noncommunicable diseases 2010. 2011. http://www.who.int/nmh/publications/ncd_report_full_en.pdf
2. World Health Organisation. Global atlas on cardiovascular disease prevention and control. 2011. whqlibdoc.who.int/publications/2011/9789241564373_eng.pdf
3. World Health Organisation. The top 10 causes of death 2013 Fact sheet no.310. 2013. http://www.who.int/mediacentre/factsheets/fs310_2008.pdf
4. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976;38:46-51.
5. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335: 136.
6. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007;93:172-6.
7. Conroy R, Pyorala K, Fitzgerald A, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
8. Assmann G, Schulte H, Cullen P, et al. Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study. Eur J Clin Invest 2007;37:925-32.
9. Ridker PM, Buring JE, Rifai N, et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women. The Reynolds Risk Score. JAMA 2007;297:611-20.
10. Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63(25 Pt B):2935-59.
11. Nelson MR, Doust JA. Primary prevention of cardiovascular disease: new guidelines, technologies and therapies. Med J Aust 2013;198:606-10.
12. Fifth Joint Task Force of the European Society of Cardiology; European Association of Echocardiography; European Association of Percutaneous Cardiovascular Interventions, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol 2012;19:585-667.
13. National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management [CG127]. 2011. https://www.nice.org.uk/guidance/cg127
14. National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification [CG181] CG 181. 2014. https://www.nice.org.uk/guidance/cg181
15. Brindle P, Beswick A, Fahey T, et al. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006;92:1752-9.
16. Willis A, Davies M, Yates T, et al. Primary prevention of cardiovascular disease using validated risk scores: a systematic review. J R Soc Med 2012;105:348-56.
17. Sheridan SL, Viera AJ, Krantz MJ, et al. The effect of giving global coronary risk information to adults: a systematic review. Arch Intern Med 2010;170:230-9.
18. Sheridan SL, Crespo E. Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Serv Res 2008;8:60.
19. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010;8:336-41.
20. Asimakopoulou KG, Fox C, Spimpolo J, et al. The impact of different time frames of risk communication on type 2 diabetes patients' understanding and memory for risk of coronary heart disease and stroke. Diabet Med 2008;25:811-17.
21. Avis NE, Smith KW, McKinlay JB. Accuracy of perceptions of heart attack risk: what influences perceptions and can they be changed? Am J Public Health 1989;79:1608-12.
22. Christensen B. Psychological reactions to information about risk of ischaemic heart disease in general practice. Scand J Prim Health Care 1995;13:164-7.
23. Christensen B, Engberg M, Lauritzen T. No long-term psychological reaction to information about increased risk of coronary heart disease in general practice. Eur J Cardiovasc Prev Rehabil 2004;11:239-43.
24. Connelly J, Cooper J, Mann A, et al. The psychological impact of screening for risk of coronary heart disease in primary care settings. J Cardiovasc Risk 1998;5:185-91.
25. Hanlon P, McEwen J, Carey L, et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ 1995;311:1609-13.
26. Hussein HM, Harris-Lane P, Abdelmoula MM, et al. Accuracy of self-perception of cardiovascular risk in the community. J Vasc Interv Neurol 2008;1:106-12.
27. Paterson JM, Llewellyn-Thomas HA, Naylor CD. Using disease risk estimates to guide risk factor interventions: field test of a patient workbook for self-assessing coronary risk. Health Expect 2002;5:3-15.
28. Persell SD, Lloyd-Jones DM, Friesema EM, et al. Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. J Gen Intern Med 2013;28:554-60.
29. Price HC, Griffin SJ, Holman RR. Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabet Med 2011;28:363-72.
30. Qureshi N, Armstrong S, Dhiman P, et al. Effect of adding systematic family history enquiry to cardiovascular disease risk assessment in primary care: a matched-pair, cluster randomized trial. Ann Intern Med 2012;156:253-62.
31. Bucher HC, Rickenbach M, Young J, et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antivir Ther 2010;15:31-40.
32. Hall LML, Jung RT, Leese GP. Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ 2003;326:251-2.
33. Hanon O, Franconi G, Mourad JJ, et al. [The estimation of cardiovascular risk in hypertensive patients is not modified by management of the hypertension]. Arch Mal Coeur Vaiss 2000;93:943-7.
34. Grover SA, Lowensteyn I, Joseph L, et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial. Arch Intern Med 2007;167:2296-303.
35. Grover SA, Lowensteyn I, Joseph L, et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. J Gen Intern Med 2009;24: 33-9.
36. Lowensteyn I, Joseph L, Levinton C, et al. Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Prev Med (Baltim) 1998;27:730-7.
37. Centers for Disease Control Division of Health Education. CDC health risk appraisal user manual. GPO Publ 1984;746-011/15. stacks.cdc.gov/view/cdc/7573/cdc_7573_DS1.pdf
38. Arizona Heart Institute. The Heart Test. http://www.azheart.com/forms/riskassessment.aspx?id=37&sid=2
39. Smith KW, McKinlay SM, Thorington BD. The validity of health risk appraisal instruments for assessing coronary heart disease risk. Am J Public Health 1987;77:419-24.
40. Blue Cross. Determine your medical age (publication #HE 0209 [3-80]. New York: Blue Cross, Blue Shield of Greater New York, 1980.
41. Anggard EE, Land JM, Lenihan CJ, et al. Prevention of cardiovascular disease in general practice: a proposed model. BMJ (Clin Res Ed) 1986;293:177-80.
42. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;2:533-7.
43. Tunstall-Pedoe H. The Dundee coronary risk-disk for management of change in risk factors. BMJ 1991;303:744-7.
44. Anderson KM, Wilson PW, Odell PM, et al. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62.
45. Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ 2000;320:709-10.
46. Waldron C-A, van der Weijden T, Ludt S, et al. What are effective strategies to communicate cardiovascular risk information to patients? A systematic review. Patient Educ Couns 2011;82: 169-81.
47. Fontana M, Asaria P, Moraldo M, et al. Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility. Circulation 2014;129:2539-46.
48. Hutchins R, Viera AJ, Sheridan SL, et al. Quantifying the utility of taking pills for cardiovascular prevention. Circ Cardiovasc Qual Outcomes 2015;8:155-63.
49. Emberson J, Whincup P, Morris R, et al. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J 2004;25:484-91.